Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Medicare Telehealth Replaces Visits, But Costs Still Rise
Care Providers Medicare Telehealth Replaces Visits, But Costs Still Rise

A comprehensive analysis of Medicare data has cemented the role of telehealth as a permanent and dominant feature in mental health care, revealing that while virtual appointments have largely replaced in-person visits rather than increasing their total number, the overall cost of these services has

Democrats Push for a Government Takeover of Health Care
Management & Administration Democrats Push for a Government Takeover of Health Care

A significant shift is underway within the Democratic Party, where the long-standing objective of defending the Affordable Care Act is being eclipsed by a far more ambitious and radical goal: the complete federal government takeover of the American healthcare industry. This movement, coalescing

Florida Enacts Sweeping Health Care Reforms
Management & Administration Florida Enacts Sweeping Health Care Reforms

Amid growing national concerns over health care accessibility and workforce shortages, Florida's legislature has enacted a series of landmark bills over the past three years, fundamentally reshaping the state's health care landscape. This comprehensive legislative overhaul, spanning the 2022, 2023,

Healthcare Leadership Shake-Up Kicks Off New Year
Tech & Innovation Healthcare Leadership Shake-Up Kicks Off New Year

The dawn of a new year has brought with it a significant realignment of leadership across the American healthcare sector, as a cascade of executive appointments and retirements redefines the strategic direction of major health systems, technology innovators, and influential advocacy organizations.

Is Pharmacy AI a Game-Changer or a Gamble?
Clinical & Pharma Is Pharmacy AI a Game-Changer or a Gamble?

The rapid integration of artificial intelligence into the pharmacy profession presents a profound and complex dilemma, forcing a critical evaluation of a technology that is simultaneously hailed as a revolutionary tool and flagged as a source of considerable, often poorly understood, risk. While

What Do New Rules Mean for Your Cervical Health?
Management & Administration What Do New Rules Mean for Your Cervical Health?

In a significant move toward modernizing preventive healthcare, federal guidelines have been updated to dismantle long-standing barriers that have hindered access to critical cervical cancer screenings for millions. For decades, the standard procedure has often involved challenges of cost, physical

Lexeo and J&J Test Heart Pump for Safer Gene Therapy
Tech & Innovation Lexeo and J&J Test Heart Pump for Safer Gene Therapy

With a rich background in medical robotics and IoT applications, James Maitland has dedicated his career to the intersection of technology and medicine. Today, he shares his perspective on a pioneering collaboration that could redefine the future of cardiac gene therapy. We'll explore how

DHL Boosts Healthcare Logistics With New Center and Acquisition
Care Providers DHL Boosts Healthcare Logistics With New Center and Acquisition

In the intricate and highly regulated world of healthcare, the journey of a life-saving medication or a critical medical device from manufacturer to patient is fraught with challenges, where a single delay or temperature deviation can have profound consequences. Responding to this high-stakes

NICE Approves Eight Asthma Apps for NHS Trial
Tech & Innovation NICE Approves Eight Asthma Apps for NHS Trial

In a significant move toward modernizing chronic disease management, England’s health technology assessment agency has provisionally endorsed a suite of digital tools designed to empower individuals living with asthma, a condition that poses daily challenges for millions. The National Institute for

Can New Drug Pacts End Patient Uncertainty?
Clinical & Pharma Can New Drug Pacts End Patient Uncertainty?

A new generation of pharmaceutical trade agreements is fundamentally reshaping the landscape of global healthcare, moving beyond abstract economic frameworks to become practical, patient-centric instruments designed to directly enhance the accessibility, affordability, and predictability of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later